VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma

Shuo Yang1,2, Ping Zhou1,2, Lelei Zhang1,2

  • 1Department of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

PubMed

Insights

Vesicle-associated membrane protein 8 (VAMP8) suppresses osteosarcoma metastasis by degrading DDX5, inhibiting WNT/β-catenin signaling and epithelial-mesenchymal transition (EMT). VAMP8 also influences autophagy, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Osteosarcoma is a bone cancer with high metastatic potential, requiring novel therapeutic strategies.
  • Vesicle-associated membrane protein 8 (VAMP8) is implicated in various cancers, but its role in osteosarcoma metastasis is unknown.

Purpose of the Study:

  • To investigate the functional role of VAMP8 in osteosarcoma metastasis.
  • To elucidate the underlying molecular mechanisms of VAMP8's action in osteosarcoma.

Main Methods:

  • Analysis of VAMP8 expression in osteosarcoma tissues and cells.
  • Assessment of VAMP8's effect on osteosarcoma cell migration and invasion.
  • Identification of VAMP8 interacting partners and investigation of downstream signaling pathways, including the ubiquitin-proteasome system, WNT/β-catenin signaling, and epithelial-mesenchymal transition (EMT).
  • Evaluation of VAMP8's impact on autophagy flux.

Main Results:

  • VAMP8 was significantly downregulated in osteosarcoma tissues and cells, correlating with poor patient prognosis.
  • VAMP8 suppressed osteosarcoma cell migration and invasion.
  • VAMP8 interacted with DDX5, promoting its proteasomal degradation, which led to reduced β-catenin levels and suppressed EMT.
  • VAMP8 promoted autophagy flux, potentially contributing to metastasis suppression.

Conclusions:

  • VAMP8 inhibits osteosarcoma metastasis through DDX5 proteasomal degradation, suppressing WNT/β-catenin signaling and EMT.
  • VAMP8-mediated autophagy dysregulation may also play a role in suppressing osteosarcoma metastasis.
  • Modulating VAMP8 presents a potential therapeutic strategy for targeting osteosarcoma metastasis.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K